Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Total Voting Rights
-
Lleida.net invoices 4,902 customers in the third quarter, up 44%
-
Upgrade of revenue and operating profit guidance
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
Form 8.5 (EPT/RI) - Pharos Energy Plc
-
Cipher, a Prosegur Company, and BIO-key Announce Technology Integration to Expand Identity Security Offering, Starting in Portugal
-
Peer-Reviewed Publication in Clinical & Experimental Allergy Reveals Potential Disease-Modifying Effect of Mabylon’s Allergen-Neutralizing Antibodies
-
Transactions in connection with share buy-back program
-
Peer-Reviewed Publication in Clinical & Experimental Allergy Reveals Potential Disease-Modifying Effect of Mabylon’s Allergen-Neutralizing Antibodies
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 02 11 2026] - (CGWL)
-
Resolutions of the Extraordinary General Meeting of shareholders of Nordic Fibreboard AS
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
UKey's Latest Firmware Passes CertiK Security Audit, With All Findings Remediated
-
UKey's Latest Firmware Passes CertiK Security Audit, With All Findings Remediated
-
Phrasly Launches a Free AI Image Detector as Fake Profile Photos, Listings, and News Images Become the Norm
-
AiMOGA’s Strategic AI Ecosystem Creates New Opportunities for LUXEED’s Intelligent Evolution
-
Global Licensing Group Rebrands as Brand Licensing by Informa: A Bold New Identity for a Booming Industry
-
Faraday Accelerates AI-Driven Manufacturing and Humanoid Robotics with EtherCAT-Compliant Ethernet PHY IP
-
Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding €0.5 Billion
-
AB Akola Group plans to invest EUR 52 million in its businesses in 2026/27
-
Third Quarter Report 2026
-
GLORIA Study Team Receives the 2026 German University Medicine Prize for Its Glioblastoma Research with CXCL12 Inhibitor NOX-A12
-
EDF: EDF announces exercise of option to redeem hybrid bonds
-
Solar A/S: No. 14 2026 Q3 EBITDA in line with expectations
-
INQ Group AB (publ) raises SEK 7 million under convertible loan facility from new US-based investment manager
-
Equinor ASA: Share buy-back – fourth tranche for 2026
-
Transaction in Own Shares
-
Progress on share buyback programme
-
AS Tallink Grupp Statistics for October 2026
-
Solar A/S: No. 13 2026 Financial calendar 2027 for Solar
-
STARTRADER Spotlights ANTHUSD Pre-IPO CFD as Anthropic Files to List on Nasdaq
-
Merck KGaA, Darmstadt, Germany, to Divest CDMO Business to Lonza
-
Merck to Divest CDMO Business to Lonza
-
Coloplast A/S - Annual Report 2025/26 & Remuneration Report 2025/26
-
Ultima Markets Strengthens European Community Connections Through Trading and Networking Event
-
New research initiative will utilise AI to optimise Nordic energy grid capacity, improve resilience and prepare for future needs
-
ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution
-
Icelandic Salmon - Third quarter 2026 results
-
International Petroleum Corporation Announces Third Quarter 2026 Financial and Operational Results
-
Strong Cresemba® (isavuconazole) sales in Europe trigger USD 37.5 million milestone payment to Basilea
-
Trifork strengthens its medical software capabilities with MDR certification and CE marking of nationwide medication solution
-
HII and Thales Successfully Demonstrate Expeditionary PathMaster's Ability to Deliver an End-to-End Autonomous Mine Countermeasure Mission
-
HII and Thales Successfully Demonstrate Expeditionary PathMaster's Ability to Deliver an End-to-End Autonomous Mine Countermeasure Mission
-
Biotalys’ First Commercial Biofungicide EVOCA® NG Approved for Large-Scale Commercial Field Trials in the Netherlands
-
Philips delivers strong order intake growth, comparable sales growth and strong margin expansion in Q3; 2026 outlook reiterated
-
Start of Day Message
-
argenx to Present at Upcoming Investor Conferences
-
WISeQey Announces Preliminary Nine-Month 2026 Financial Results and Provides Corporate Update
-
Invitation to Idorsia's webcast and conference call to provide more context on the opportunity and launch approach for TRYVIO/JERAYGO
-
Wereldhave Trading update Q3 2026
